These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3365933)

  • 41. [Standardization of the thromboplastin time determination].
    Dati F
    Z Med Lab Diagn; 1990; 31(4):211-24. PubMed ID: 2382469
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prothrombin time in the monitoring of oral anticoagulant: a comparison of results using different thromboplastins.
    Guglielmone HA; Vides MA
    Ann Biol Clin (Paris); 1990; 48(8):547-50. PubMed ID: 2288441
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An evaluation of chromogenic substrates in the control of oral anticoagulant therapy.
    Latallo ZS; Thomson JM; Poller L
    Br J Haematol; 1981 Feb; 47(2):307-18. PubMed ID: 7470395
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Standardization of the prothrombin time in oral anticoagulant control.
    van den Besselaar AM
    Haemostasis; 1985; 15(4):271-7. PubMed ID: 4043828
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinically significant differences in the International Normalized Ratio measured with reagents of different sensitivities. SPAF Investigators. Stroke Prevention in Atrial Fibrillation.
    Lind SE; Pearce LA; Feinberg WM; Bovill EG
    Blood Coagul Fibrinolysis; 1999 Jul; 10(5):215-27. PubMed ID: 10456611
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phospholipid composition controls thromboplastin sensitivity to individual clotting factors.
    Smith SA; Comp PC; Morrissey JH
    J Thromb Haemost; 2006 Apr; 4(4):820-7. PubMed ID: 16634752
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Precision and accuracy of the international normalized ratio in oral anticoagulant control.
    van den Besselaar AM
    Haemostasis; 1996 Oct; 26 Suppl 4():248-65. PubMed ID: 8979131
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of therapeutic quality control in a long-term anticoagulant trial in post-myocardial infarction patients.
    Azar AJ; Deckers JW; Rosendaal FR; van Bergen PF; van der Meer FJ; Jonker JJ; Briët E
    Thromb Haemost; 1994 Sep; 72(3):347-51. PubMed ID: 7855782
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The significance of the International Normalized Ratio (INR) for oral anticoagulant therapy.
    van den Besselaar AM
    J Int Fed Clin Chem; 1991 Sep; 3(4):146-53. PubMed ID: 20821873
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Implications of use of low international sensitivity index thromboplastins in prothrombin time testing.
    Ts'ao C; Swedlund J; Neofotistos D
    Arch Pathol Lab Med; 1994 Dec; 118(12):1183-7. PubMed ID: 7979911
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Screening INR deviation of local prothrombin time systems.
    Poller L
    J Clin Pathol; 1998 May; 51(5):356-9. PubMed ID: 9708200
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ASHP therapeutic position statement on the use of the International Normalized Ratio system to monitor oral anticoagulant therapy.
    Am J Health Syst Pharm; 1995 Mar; 52(5):529-31. PubMed ID: 7606561
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Standardization of prothrombin time for laboratory control of oral anticoagulant therapy.
    Kitchen S; Preston FE
    Semin Thromb Hemost; 1999; 25(1):17-25. PubMed ID: 10327216
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of international sensitivity index (ISI) of thromboplastins on precision of international normalised ratios (INR).
    Taberner DA; Poller L; Thomson JM; Darby KV
    J Clin Pathol; 1989 Jan; 42(1):92-6. PubMed ID: 2921349
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anticoagulant therapy monitoring with international normalized ratio at US academic health centers.
    Yim JM; Albers GW; Vlasses PH
    Ann Pharmacother; 1996 Dec; 30(12):1390-5. PubMed ID: 8968449
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of the choice of WHO International Reference Preparation for thromboplastin on International Normalised Ratios.
    Poller L; Taberner DA; Thomson JM; Morris J; Mibashan RS; Shinton NK
    J Clin Pathol; 1993 Jan; 46(1):64-6. PubMed ID: 8432892
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Special report: a simple system for the derivation of International Normalized Ratios for the reporting of prothrombin time results with North American thromboplastin reagents.
    Poller L; Hirsh J
    Am J Clin Pathol; 1989 Jul; 92(1):124-6. PubMed ID: 2750702
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A critical evaluation of the prothrombin time for monitoring oral anticoagulant therapy.
    Jackson CM; Esnouf MP; Lindahl TL
    Pathophysiol Haemost Thromb; 2003; 33(1):43-51. PubMed ID: 12853712
    [TBL] [Abstract][Full Text] [Related]  

  • 59. International Normalized Ratio (INR): an improved way to monitor oral anticoagulant therapy.
    Oertel LB
    Nurse Pract; 1995 Sep; 20(9):15-6, 21-2. PubMed ID: 7501312
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Calibration verification of the International Normalized Ratio.
    Critchfield GC; Bennett ST; Swaim WR
    Am J Clin Pathol; 1996 Dec; 106(6):786-94. PubMed ID: 8980356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.